Point and Counterpoint
Cox - 2 Inhibitors and Cardiovascular Risk
The data are inconclusive, and these drugs are needed
John Lipani, MD
Cleveland Clinic Journal of Medicine November 2001, 68 (11) 961-962;
John Lipani
Clinical rheumatologist and researcher; president, Histatek Inc., Fountain Hills, AZ


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 68, Issue 11
1 Nov 2001
Cox - 2 Inhibitors and Cardiovascular Risk
John Lipani
Cleveland Clinic Journal of Medicine Nov 2001, 68 (11) 961-962;
Jump to section
Related Articles
- No related articles found.